Physician profile
Michael Won Lee
NPI 1275590523
$10,182.64
in general payments reported to CMS, 2019-2025
31 companies · $2,090 in 2025
The $2,090 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,883 · 2020: $684 · 2021: $1,464 · 2022: $1,531 · 2023: $1,440 · 2024: $1,090 · 2025: $2,090.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,620.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,620.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,534.49 | 2021-2025 | Avalus, Corevalve Evolut R, Freestyle |
| Abbott Laboratories | $1,254.96 | 2019-2025 | Amplatzer Amulet, Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Amgen INC. | $1,204.44 | 2019-2025 | Repatha, Repatha |
| Medtronic Vascular, INC. | $1,055.58 | 2019-2020 | |
| Edwards Lifesciences Corporation | $671.77 | 2019-2025 | Mitris Resilia Mitral Valve, Sapien 3 Ultra Resilia |
| Chiesi USA, INC. | $349.42 | 2023-2025 | Cleviprex, Kengreal |
| Philips North America LLC | $306.81 | 2020-2025 | IV Other |
| Kestra Medical Technology Services, INC. | $264.27 | 2024-2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $255.41 | 2022-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $244.74 | 2019-2020 | |
| Genzyme Corporation | $233.32 | 2022-2023 | |
| Ethicon US, LLC | $216.64 | 2025 | Harmonic, Enseal, Echelon; Endopath |
| Pfizer INC. | $177.37 | 2019-2025 | |
| W. L. Gore & Associates, INC. | $134.67 | 2021 | |
| Novartis Pharmaceuticals Corporation | $134.04 | 2019-2024 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $124.99 | 2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $123.97 | 2021 | |
| Impulse Dynamics (USA) INC. | $122.19 | 2024 | Optimizer |
| Sanofi-Aventis U.S. LLC | $119.31 | 2019 | |
| Atricure, INC. | $114.89 | 2019 | |
| Boston Scientific Corporation | $103.73 | 2020 | |
| Abiomed | $85.11 | 2022 | |
| Opsens INC. | $76.71 | 2022 | |
| Getinge USA Sales, LLC | $58.70 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $58.09 | 2024-2025 | Wainua |
| Ethicon INC. | $37.54 | 2024 | Monarch Platform |
| Becton, Dickinson and Company | $37.13 | 2025 | Hemosphere |
| Pinnacle, INC | $29.74 | 2024 | |
| Csl Behring | $23.73 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $17.23 | 2019 | |
| Bard Access Systems, INC. | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.